The Pittsburgh Life Sciences Greenhouse
The PLSG stated mission is to create, nurture and help establish a globally dominant life sciences industry in western Pennsylvania. PLSG primarily focuses on guiding researchers, entrepreneurs, and emerging companies through the challenges faced in the early stages of company development by advising them on business models and capital investments in order to help speed the delivery of biomedical innovations to the marketplace. The PLSG also helps in the expansion of more mature life science companies by supporting new product and market developments and by connecting them to new investors.
The PLSG is funded based on a revolving funding model that provides returning revenue which supports the ongoing growth of regional industry. In addition, the PLSG receives funding from the Commonwealth of Pennsylvania's Department of Community and Economic Development and Southwestern Pennsylvania's philanthropic foundation community. The PLSG has committed over $11.3 million into 50 life sciences companies and has attracted over $300 million in follow-on funding for those emerging business.
The PLSG stated mission is to create, nurture and help establish a globally dominant life sciences industry in western Pennsylvania. PLSG primarily focuses on guiding researchers, entrepreneurs, and emerging companies through the challenges faced in the early stages of company development by advising them on business models and capital investments in order to help speed the delivery of biomedical innovations to the marketplace. The PLSG also helps in the expansion of more mature life science companies by supporting new product and market developments and by connecting them to new investors.
The PLSG is funded based on a revolving funding model that provides returning revenue which supports the ongoing growth of regional industry. In addition, the PLSG receives funding from the Commonwealth of Pennsylvania's Department of Community and Economic Development and Southwestern Pennsylvania's philanthropic foundation community. The PLSG has committed over $11.3 million into 50 life sciences companies and has attracted over $300 million in follow-on funding for those emerging business.
BioAdvance, Biotechnology Greenhouse of Southeastern Pennsylvannia
BioAdvance is an evergreen fund that invests between $5,000 and $1.5 million in pre-seed and seed-stage life science companies in the Greater Philadelphia region.
BioAdvance is an evergreen fund that invests between $5,000 and $1.5 million in pre-seed and seed-stage life science companies in the Greater Philadelphia region.
North Carolina Biotechnology Center
The North Carolina Biotechnology Center has been driving the growth of the biotechnology industry in North Carolina since its establishment in 1984. The Center is a job creation engine through direct funding of companies and academic institutions across the state and through connections to investors, partners, service providers and employees in North Carolina and beyond.
The North Carolina Biotechnology Center has been driving the growth of the biotechnology industry in North Carolina since its establishment in 1984. The Center is a job creation engine through direct funding of companies and academic institutions across the state and through connections to investors, partners, service providers and employees in North Carolina and beyond.
Technology Development Corporation (TEDCO)
TEDCO is a key resource for mentoring, funding, and networking for entrepreneurs and start-up companies as they bring innovative concepts to market.
TEDCO is a key resource for mentoring, funding, and networking for entrepreneurs and start-up companies as they bring innovative concepts to market.
Avalon Ventures
Avalon Ventures is a venture capital firm that has founded and/or funded more than 100 information technology and life sciences companies. The firm is passionate about backing talented entrepreneurs seeking to build market-leading companies. Throughout the firm’s 30 year tenure, Avalon’s long-standing and successful focus has been on seed and early-stage companies. All Avalon partners are seasoned entrepreneurs with experience in company formation, operations and value creation in the life science and tech sectors. A hallmark of Avalon is working closely with our companies on all aspects of its development – ranging from team building to strategy and operations to customer development.
Avalon Ventures is a venture capital firm that has founded and/or funded more than 100 information technology and life sciences companies. The firm is passionate about backing talented entrepreneurs seeking to build market-leading companies. Throughout the firm’s 30 year tenure, Avalon’s long-standing and successful focus has been on seed and early-stage companies. All Avalon partners are seasoned entrepreneurs with experience in company formation, operations and value creation in the life science and tech sectors. A hallmark of Avalon is working closely with our companies on all aspects of its development – ranging from team building to strategy and operations to customer development.
Ben Franklin Technology Partners
The award-winning Ben Franklin Technology Partners is one of the nation’s longest-running technology-based economic development programs. For more than 30 years, BFTP has provided both early-stage and established companies with funding, business and technical expertise and access to a network of innovative, expert resources.
The award-winning Ben Franklin Technology Partners is one of the nation’s longest-running technology-based economic development programs. For more than 30 years, BFTP has provided both early-stage and established companies with funding, business and technical expertise and access to a network of innovative, expert resources.
Hatteras Venture Partners
Hatteras Venture Partners is a venture capital firm formed to invest primarily in early stage companies with a focus on biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportunities in human medicine. The firm will typically invest in companies located in the research-driven regions of North Carolina and the Southeastern United States, which are undercapitalized in comparison to New England and California.
Hatteras Venture Partners is a venture capital firm formed to invest primarily in early stage companies with a focus on biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportunities in human medicine. The firm will typically invest in companies located in the research-driven regions of North Carolina and the Southeastern United States, which are undercapitalized in comparison to New England and California.
Harbert Venture Partners
HMC is an independent investment firm focused on fundamentally-based private and public market strategies. We seek investments forecasted to yield mid- to high-teen returns. Our mission is to provide strong and consistent returns to help our clients meet their investment objectives and preserve initial investment capital. We are opportunistic investors who invest alongside our clients on equal terms and conditions.
HMC is an independent investment firm focused on fundamentally-based private and public market strategies. We seek investments forecasted to yield mid- to high-teen returns. Our mission is to provide strong and consistent returns to help our clients meet their investment objectives and preserve initial investment capital. We are opportunistic investors who invest alongside our clients on equal terms and conditions.
